December 29, 2012
FDA's plan to create a tiered oversight system for traditional and non-traditional compounding would address a growing area of risk without creating “huge dislocations” within the healthcare system, which has become increasingly dependent on outsourcing certain functions to large-scale compounders, said FDA Commissioner Margaret Hamburg as she met with regulators from 50 states last week.
Source found here (subscription required)
No comments:
Post a Comment